Rachel Raab

569 total citations
14 papers, 171 citations indexed

About

Rachel Raab is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Rachel Raab has authored 14 papers receiving a total of 171 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Rachel Raab's work include Pharmacogenetics and Drug Metabolism (4 papers), Estrogen and related hormone effects (3 papers) and Breast Cancer Treatment Studies (3 papers). Rachel Raab is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Estrogen and related hormone effects (3 papers) and Breast Cancer Treatment Studies (3 papers). Rachel Raab collaborates with scholars based in United States, Germany and India. Rachel Raab's co-authors include Joseph J. Weber, Jan H. Wong, Kent W. Hunter, Kevin Gardner, Maxwell Lee, Sven Bilke, Charles M. Perou, Cecilia Zvosec, Jung S. Byun and Howard H. Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Rachel Raab

13 papers receiving 169 citations

Peers

Rachel Raab

ONCOL

GENET

GHP

Kirsten B. Moysich United States

Maria Ekholm Sweden

Leslie E. Oldfield Canada

S. Palazzo Italy

Richard Papworth United Kingdom

Mun N. Hui Australia

Kent Hoskins United States

Lisen Axell United States

Anja Ør Knudsen Denmark

Amber N. Hurson United States

Kirsten B. Moysich United States

Rachel Raab

51 ×0.5

28 ×0.5

ONCOL

48 ×1.2

72 ×2.1

GENET

12 ×1.0

GHP

Citations per year, relative to Rachel Raab Rachel Raab (= 1×) peers Kirsten B. Moysich

Countries citing papers authored by Rachel Raab

Since Specialization

Citations

This map shows the geographic impact of Rachel Raab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Raab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Raab more than expected).

Fields of papers citing papers by Rachel Raab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Raab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Raab. The network helps show where Rachel Raab may publish in the future.

Co-authorship network of co-authors of Rachel Raab

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Raab. A scholar is included among the top collaborators of Rachel Raab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Raab. Rachel Raab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Gardner, Kevin, Howard H. Yang, Cheng Fan, et al.. (2020). Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. UNC Libraries. 3 indexed citations

Dressler, Lynn G., Gillian C. Bell, Mark Steciuk, et al.. (2019). Implementing a Personalized Medicine Cancer Program in a Community Cancer System. Personalized Medicine. 16(3). 221–232. 6 indexed citations

Raab, Rachel, et al.. (2016). Neoadjuvant metronomic chemotherapy in triple-negative breast cancer (TNBC) (NCT00542191): Updated results from a phase II trial.. Journal of Clinical Oncology. 34(15_suppl). e12502–e12502. 2 indexed citations

Hertz, Daniel L., Anna C. Snavely, Howard L. McLeod, et al.. (2015). Abstract P1-03-02: CYP2D6 intermediate metabolizers includes patient groups with distinct metabolic activity. Cancer Research. 75(9_Supplement). P1–3. 1 indexed citations

Hertz, Daniel L., Anna C. Snavely, James P. Evans, et al.. (2014). Does increasing the daily tamoxifen dose in patients with diminished CYP2D6 activity increase toxicity?. Journal of Clinical Oncology. 32(15_suppl). 561–561. 3 indexed citations

Byun, Jung S., Madeline Wong, Clay Wakano, et al.. (2013). Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer. Nature Communications. 4(1). 1449–1449. 97 indexed citations

Biswas, Tithi, Timothy M. Zagar, Jimmy T. Efird, et al.. (2013). Insurance status as a strong predictor of outcome in triple-negative breast cancer (TNBC): A multi-institutional retrospective study.. Journal of Clinical Oncology. 31(15_suppl). 1069–1069. 1 indexed citations

Weber, Joseph J., et al.. (2012). Patient Navigation and the Quality of Breast Cancer Care: An Analysis of the Breast Cancer Care Quality Indicators. Annals of Surgical Oncology. 19(10). 3251–3256. 34 indexed citations

Raab, Rachel, et al.. (2012). Results of the East Carolina Breast Center phase II trial of neoadjuvant metronomic chemotherapy in triple-negative breast cancer (NCT00542191).. Journal of Clinical Oncology. 30(15_suppl). e11550–e11550. 3 indexed citations

10.

Raab, Rachel, Joseph A. Sparano, Allyson J. Ocean, et al.. (2010). A Phase I Trial of Oblimersen Sodium in Combination With Cisplatin and 5-Fluorouracil in Patients With Advanced Esophageal, Gastroesophageal Junction, and Gastric Carcinoma. American Journal of Clinical Oncology. 33(1). 61–65. 13 indexed citations

11.

Irvin, William, Lisa A. Carey, E. Claire Dees, et al.. (2009). Patients' Understanding of a CYP2D6 Tamoxifen Genotyping Study.. Cancer Research. 69(24_Supplement). 6082–6082. 1 indexed citations

12.

Irvin, William, Lisa A. Carey, E. Claire Dees, et al.. (2009). Validating CYP2D6 Genotype-Guided Tamoxifen Therapy for a Multiracial U.S. Population.. Cancer Research. 69(24_Supplement). 410–410. 2 indexed citations

13.

Lang, Hauke, Silvio Nadalin, Laura Moreno, et al.. (2000). Isolated Hyperthermic Liver Perfusion with High Dose Tumor Necrosis Factor Alpha in Pigs: An Experimental Study in Preparation of Clinical Use. European Surgical Research. 32(1). 1–10. 5 indexed citations

14.

Sauer, Rolf, et al.. (2000). . Der Onkologe. 6(6). 584–586.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact